Yesterday afternoon the MiCells team attended AWS Future Builders at HKSTP - Hong Kong Science and Technology Park.
Werner Vogels gave a facinating keynote speech regarding AI and how its here to help not hinder our development.
As an #HKSTP based startup, weโre building toward a new category of private healthcare: the world first commercial private blood bank.
Learning, connecting and building from Hong Kong.
#MiCells #HKSTP #AWS #Biotech #HealthTech
Recent research confirms autologous peripheral blood stem cells maintain high viability and functional properties after up to 30 years of cryogenic storage. Such findings strengthen the foundation for long-term biological assurance. #MiCells#AutologousBlood#CryogenicStewardship From https://t.co/cF99hHe8yj
Most critical assets demand foresight. Portfolios are diversified. Intellectual property is safeguarded. Yet personal biology often relies on uncertain public systems. Structured autologous readiness addresses this gap with precision.
Today marks an important milestone for #MiCells.
We have formally filed our first patent application covering the core technical architecture underlying our platform.
The team has been working quietly on this for some time, and weโre excited to take the next step in building and protecting the technology behind MiCells.
Alongside our registered trademark, this marks another important step as we continue developing the company and preparing for our next stage of growth.
Building a proprietary foundation takes relentless focus, and I couldn't be prouder of the momentum we are building.
Follow our journey here:
https://t.co/YLzrt6lMYa
A huge thank you to everyone supporting, challenging & advising us behind the scenes.
High-net-worth families increasingly prioritize comprehensive asset protection that includes biological resources. Autologous banking offers unmatched control, compatibility, and resilience against unforeseen health events. #MiCells#PersonalBiologicalSecurity
Advances in cryoprotectant formulations continue to enhance post-thaw recovery rates, supporting the long-term viability of stored autologous units. From https://t.co/vg1LYcazd1
A first look at the #MiCells client-facing application.
We are developing a secure digital experience designed to guide clients through the management and, when required, redemption of their own stored blood.
The application is one component of a much broader system spanning clinical governance, testing, cryogenic storage, verification and chain of custody.
This walkthrough shows an early version of the client journey as we continue developing and refining the MiCells platform.
We believe personal biological preparedness should be built around the individual with greater control, continuity and visibility over their own biological material.
More to come ๐ค
๐๐ช๐ด๐ค๐ญ๐ข๐ช๐ฎ๐ฆ๐ณ: ๐ต๐ฉ๐ฆ ๐ธ๐ข๐ญ๐ฌ๐ต๐ฉ๐ณ๐ฐ๐ถ๐จ๐ฉ ๐ช๐ฏ๐ค๐ญ๐ถ๐ฅ๐ฆ๐ด ๐ช๐ญ๐ญ๐ถ๐ด๐ต๐ณ๐ข๐ต๐ช๐ท๐ฆ ๐ฆ๐น๐ข๐ฎ๐ฑ๏ฟฝ๏ฟฝ๏ฟฝ๏ฟฝ๐ฆ๐ด ๐ฐ๐ง ๐ฉ๐ฐ๐ธ ๐ฆ๐ญ๐ฆ๐ฎ๐ฆ๐ฏ๐ต๐ด ๐ฐ๐ง ๐ต๐ฉ๐ฆ ๐ค๐ญ๐ช๐ฆ๐ฏ๐ต ๐ซ๐ฐ๐ถ๐ณ๐ฏ๐ฆ๐บ ๐ฎ๐ข๐บ ๐ข๐ฑ๐ฑ๐ฆ๐ข๐ณ ๐ช๐ฏ ๐ต๐ฉ๐ฆ ๐ง๐ช๐ฏ๐ข๐ญ ๐ฑ๐ญ๐ข๐ต๐ง๐ฐ๐ณ๐ฎ. ๐๐ฑ๐ฆ๐ค๐ช๐ง๐ช๐ค ๐ฑ๐ณ๐ฐ๐ท๐ช๐ฅ๐ฆ๐ณ๐ด ๐ข๐ฏ๐ฅ ๐ญ๐ฐ๐ค๐ข๐ต๐ช๐ฐ๐ฏ๐ด ๐ด๐ฉ๐ฐ๐ธ๐ฏ ๐ข๐ณ๐ฆ ๐ง๐ฐ๐ณ ๐ฅ๐ฆ๐ฎ๐ฐ๐ฏ๐ด๐ต๐ณ๐ข๐ต๐ช๐ฐ๐ฏ ๐ฑ๐ถ๐ณ๐ฑ๐ฐ๐ด๐ฆ๐ด ๐ฐ๐ฏ๐ญ๐บ.
#MiCells #Biotechnology #HealthTech #DigitalHealth #HKSTP #HKSTPIdeation #HongKong #MidnightFoundation
Recent 2026 research published in Cryotherapy confirms autologous peripheral blood stem cells retain high viability and functional properties after up to 30 years of cryostorage. Such findings reinforce the foundation for long-term personal biological security.
From https://t.co/V8lQybYGoZ
A growing body of evidence on cryopreserved autologous material highlights retained clonogenic potential even after extended storage periods. Such science underpins the rationale for proactive biological structuring. From https://t.co/AZsMtD2i66
For individuals with rare blood types, reliance on public inventories can introduce critical delays. Private autologous banking removes these variables, providing lifetime readiness independent of external factors. #BiologicalAssurance
A significant week for MiCells.
We are very pleased to officially announce and begin our journey within the HKSTP - Hong Kong Science and Technology Parks Corporation ecosystem following the welcome session for the #HKSTPIdeation programme attended by our Founder & CEO Ben Cooper and our Co-Founder & CTO Clint Pavlovic.
As a Hong Kong-based biotechnology and medical venture, joining one of Asiaโs leading innovation and research ecosystems represents an important milestone for #MiCells. The programme provides an environment in which we can further develop our scientific, technical and commercial foundations as we work towards our vision for long-term personal blood banking and biological assurance.
Alongside our work within the HKSTP Startup Ecosystem, our engineering team has continued developing the technology underpinning our privacy-preserving verification infrastructure. Our MiCells Midnight Relay is now live on @MidnightNtwrk mainnet and actively participating in the network, providing an early foundation for exploring how privacy-preserving technology could be applied to the secure verification of biological assets.
This may be viewed here:
https://t.co/GuUEm7bmYU
We are building MiCells at the intersection of biotechnology, healthcare, privacy and secure biological infrastructure from #HongKong, with an international ambition.
We are grateful to the #HKSTP team for the warm welcome and look forward to the journey ahead.
#MiCells #HKSTP #HongKongSciencePark #HongKong #Biotechnology #Healthcare #DeepTech #DataPrivacy #Longevity #Innovation
Advanced vapor-phase cryogenic systems at MiCells maintain temperatures below โ150ยฐC, preserving cellular integrity with the highest standards of traceability and governance. When required, units are prepared for seamless clinical deployment.